SYNTHESIS OF ANTICANCER AGENTS

抗癌剂的合成

基本信息

  • 批准号:
    7768452
  • 负责人:
  • 金额:
    $ 51.74万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-04-01 至 2011-02-28
  • 项目状态:
    已结题

项目摘要

This grant application describes the proposed total syntheses of a number of potent antitumor agents of natural origin, namely lomaiviticins A and B, cytoskyrin A, amphidinolide N and caribenolide I, as well as a number of related molecules for biological screening. The proposed total synthesis of the lomaiviticins would involve the dimerization of an advanced a-halo enone intermediate to generate the C2-symmetric polycyclic framework. Further elaboration of the sterically crowded central core would then be facilitated by the temporary incorporation of a bridging cyclic tether. Two alternative such tethers have been devised, namely a tetrahydrothiophene and a carbocycle bearing a pendant ester group, increasing the flexibility of the overall strategy. Once the required structural motifs are installed, either of these bridges could be oxidatively cleaved to reveal the necessary functionalities for completion of the target molecules. For cytoskyrin A, a biomimetic cascade process to furnish the cage-like framework of the target molecule has been experimentally demonstrated. Involving the acid-catalyzed dimerization of an anthraquinone derivative followed by a bis-enolization/ double intramolecular Michael addition sequence, careful monitoring of this cascade allows for the selective generation of the central core of not only cytoskyrin A, but also that of a number of other structurally related biologically active natural products. This cascade process would be amenable to the production of not only these natural products themselves, but also to that of specifically targeted analogs, which would be screened for antitumor activity. The proposed syntheses of amphidinolide N and caribenolide I feature a unified, highly convergent strategy involving the sequential asymmetric alkylation of a chiral 1,3-dihydroxyacetone equivalent to establish the complete carbon framework of the target molecules, followed by a highly selective macrolactonization to generate the 26-membered ring in each case. The significance of the proposed work will lie specifically in the area of cancer chemotherapy research, and in the development of new synthetic strategies and technologies for general use in the drug discovery and development process.
本拨款申请描述了一些强效抗肿瘤药物的拟议全合成

项目成果

期刊论文数量(12)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The true structures of the vannusals, part 1: Initial forays into suspected structures and intelligence gathering.
  • DOI:
    10.1002/anie.200902028
  • 发表时间:
    2009
  • 期刊:
  • 影响因子:
    16.6
  • 作者:
    Nicolaou, K. C.;Zhang, Hongjun;Ortiz, Adrian
  • 通讯作者:
    Ortiz, Adrian
Total synthesis and biological evaluation of (+)- and (-)-bisanthraquinone antibiotic BE-43472B and related compounds.
  • DOI:
    10.1021/ja9073694
  • 发表时间:
    2009-10-21
  • 期刊:
  • 影响因子:
    15
  • 作者:
    Nicolaou, K. C.;Becker, Jochen;Lim, Yee Hwee;Lemire, Alexandre;Neubauer, Thomas;Montero, Ana
  • 通讯作者:
    Montero, Ana
Total syntheses of (+/-)-platencin and (-)-platencin.
  • DOI:
    10.1021/ja906801g
  • 发表时间:
    2009-11-04
  • 期刊:
  • 影响因子:
    15
  • 作者:
    Nicolaou, K. C.;Tria, G. Scott;Edmonds, David J.;Kar, Moumita
  • 通讯作者:
    Kar, Moumita
Asymmetric total synthesis of cylindrocyclophanes A and F through cyclodimerization and a Ramberg-Bäcklund reaction.
  • DOI:
    10.1002/anie.201003500
  • 发表时间:
    2010-08-09
  • 期刊:
  • 影响因子:
    16.6
  • 作者:
    Nicolaou, K. C.;Sun, Ya-Ping;Korman, Henry;Sarlah, David
  • 通讯作者:
    Sarlah, David
The true structures of the vannusals, part 2: Total synthesis and revised structure of vannusal B.
  • DOI:
    10.1002/anie.200902029
  • 发表时间:
    2009
  • 期刊:
  • 影响因子:
    16.6
  • 作者:
    Nicolaou, K. C.;Ortiz, Adrian;Zhang, Hongjun
  • 通讯作者:
    Zhang, Hongjun
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

K. C. NICOLAOU其他文献

K. C. NICOLAOU的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('K. C. NICOLAOU', 18)}}的其他基金

SYNTHESIS OF ANTICANCER AGENTS
抗癌剂的合成
  • 批准号:
    7568872
  • 财政年份:
    2006
  • 资助金额:
    $ 51.74万
  • 项目类别:
SYNTHESIS OF ANTICANCER AGENTS
抗癌剂的合成
  • 批准号:
    7357462
  • 财政年份:
    2006
  • 资助金额:
    $ 51.74万
  • 项目类别:
SYNTHESIS OF ANTICANCER AGENTS
抗癌剂的合成
  • 批准号:
    7090326
  • 财政年份:
    2006
  • 资助金额:
    $ 51.74万
  • 项目类别:
TOTAL SYNTHESIS OF KINAMYCINS AND LOMAIVITICINS
运动霉素和洛马霉素的全合成
  • 批准号:
    7215159
  • 财政年份:
    2006
  • 资助金额:
    $ 51.74万
  • 项目类别:
Synthesis of Marine Neurotoxins
海洋神经毒素的合成
  • 批准号:
    7626848
  • 财政年份:
    2005
  • 资助金额:
    $ 51.74万
  • 项目类别:
Synthesis of Marine Neurotoxins
海洋神经毒素的合成
  • 批准号:
    7821404
  • 财政年份:
    2005
  • 资助金额:
    $ 51.74万
  • 项目类别:
Synthesis of Marine Neurotoxins
海洋神经毒素的合成
  • 批准号:
    8067814
  • 财政年份:
    2005
  • 资助金额:
    $ 51.74万
  • 项目类别:
Synthesis of Marine Neurotoxins
海洋神经毒素的合成
  • 批准号:
    7257976
  • 财政年份:
    2005
  • 资助金额:
    $ 51.74万
  • 项目类别:
TOTAL SYNTHESIS OF AZASPIRACIDS
氮杂螺酸的全合成
  • 批准号:
    6955695
  • 财政年份:
    2005
  • 资助金额:
    $ 51.74万
  • 项目类别:
TOTAL SYNTHESIS OF AZASPIRACIDS
氮杂螺酸的全合成
  • 批准号:
    7082128
  • 财政年份:
    2005
  • 资助金额:
    $ 51.74万
  • 项目类别:

相似海外基金

Studies of Chemically Labile Alkylation Damage in DNA
DNA 中化学不稳定烷基化损伤的研究
  • 批准号:
    10735154
  • 财政年份:
    2023
  • 资助金额:
    $ 51.74万
  • 项目类别:
The role of histidine phosphorylation in the DNA alkylation damage response
组氨酸磷酸化在 DNA 烷基化损伤反应中的作用
  • 批准号:
    10581923
  • 财政年份:
    2023
  • 资助金额:
    $ 51.74万
  • 项目类别:
Studies of Chemically Labile Alkylation Damage in DNA
DNA 中化学不稳定烷基化损伤的研究
  • 批准号:
    10769108
  • 财政年份:
    2023
  • 资助金额:
    $ 51.74万
  • 项目类别:
DABCO and Quinuclidine as HAT Catalysts in Direct Arylation and Alkylation of Aldehyde's C-H Bonds via Photoredox Catalysis: A computational stud
DABCO 和奎宁环作为 HAT 催化剂通过光氧化还原催化醛的 C-H 键直接芳基化和烷基化:一项计算研究
  • 批准号:
    2876395
  • 财政年份:
    2022
  • 资助金额:
    $ 51.74万
  • 项目类别:
    Studentship
CAREER: Engineered SAM-Dependent Enzymes for Stereoselective Alkylation Reactions
职业:用于立体选择性烷基化反应的工程 SAM 依赖性酶
  • 批准号:
    2145749
  • 财政年份:
    2022
  • 资助金额:
    $ 51.74万
  • 项目类别:
    Standard Grant
Characterizing the role of RNF25 in repair of DNA alkylation in blood cancers
表征 RNF25 在血癌 DNA 烷基化修复中的作用
  • 批准号:
    10438061
  • 财政年份:
    2022
  • 资助金额:
    $ 51.74万
  • 项目类别:
Characterizing the role of RNF25 in repair of DNA alkylation in blood cancers
表征 RNF25 在血癌 DNA 烷基化修复中的作用
  • 批准号:
    10580070
  • 财政年份:
    2022
  • 资助金额:
    $ 51.74万
  • 项目类别:
Alkyl(aryl)iodonium Reagents for Late-Stage Alkylation
用于后期烷基化的烷基(芳基)碘鎓试剂
  • 批准号:
    EP/W00934X/1
  • 财政年份:
    2022
  • 资助金额:
    $ 51.74万
  • 项目类别:
    Research Grant
Ketone Alkylation Using Simple Olefins: A Sustainable Chemistry Approach
使用简单烯烃进行酮烷基化:一种可持续的化学方法
  • 批准号:
    2154632
  • 财政年份:
    2022
  • 资助金额:
    $ 51.74万
  • 项目类别:
    Standard Grant
Development of New Methods for Asymmetric Synthesis and Nitrogen Fixation by using dihydropyridine derivatives as Alkylation Reagents
以二氢吡啶衍生物为烷基化试剂开发不对称合成和固氮新方法
  • 批准号:
    22J14253
  • 财政年份:
    2022
  • 资助金额:
    $ 51.74万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了